Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belarus
  Belgium
  Benin
  Botswana
  Brazil
  Bulgaria
  Cameroon
  Canada
  Chile
  China
  Colombia
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lichtenstein
  Lithuania
  Luxembourg
  Madagascar
  Malta
  Mexico
  Montenegro
  Morocco
  Namibia
  Netherlands
  Nigeria
  Norway
  Peru
  Poland
  Portugal
  Romania
  Russia
  Senegal
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tanzania
  Tunisia
  Turkey
  Uganda
  Ukraine
  United Kingdom
  United States


   Infocentre

Last Update: 05-01-2011  
Related category(ies):
Health & life sciences  |  Research policy

 

Add to PDF "basket"

EU project develops 'in-office' health test system

One of the most nerve-racking things about being tested for some medical condition is the long wait you endure while you wait for your results to come in. It could take anywhere from a few days to a couple of weeks to know your results. But EU-funded researchers are changing all this. The MICROACTIVE ('Automatic detection of disease related molecular cell activity') project has developed a microchip that allows physicians to diagnose a patient's condition right in their office. MICROACTIVE received EUR 1.6 million under the EU's Sixth Framework Programme (FP6).

Sample set for lab work © SINTEF
Sample set for lab work
©  SINTEF

The advanced integrated system, which is based on microtechnology and biotechnology, helps keep your medical testing information at the doctor's office instead of being sent to a laboratory. This tiny chip gives the doctor your test results then and there.

For instance, a blood sample whose protein content and genes, among other things, are to be read must be submitted to a series of complex processes, including heat treatment, mixing with enzymes, centrifugation and concentration of disease markers. What this means is that central laboratories receive the samples and perform analyses. This is a time-consuming process. Another case in point is tests for cervical cancer. The sample of cells that are scraped from a woman's cervix are analysed under the microscope. Experts say diagnostic error rates can be high when abnormal cell appearance is determined by even experienced eyes.

According to the MICROACTIVE team, the new 'health chip' contains a complete laboratory and resembles a credit card. While the partners used cells taken to diagnose cervical cancer as a case study, the chip can actually assess various diseases triggered by bacteria or viruses, as well as different types of cancer.

Several narrow channels containing chemicals and enzymes in the correct proportions for single analyses are engraved in the chip. When the patient's sample has been drawn into the channels, these reagants are mixed.

'The health chip can analyse your blood or cells for eight different diseases,' explained Liv Furuberg and Michal Mielnik of the Norwegian-based group SINTEF, the coordinating body of MICROACTIVE. 'What these diseases have in common is that they are identified by means of special biomarkers that are found in the blood sample. These "labels" may be proteins that either ought or ought not to be there, DNA [deoxyribonucleic acid] fragments or enzymes. This little chip is capable of carrying out the same processes as a large laboratory, and not only does it perform them faster, but the results are also far more accurate. The doctor simply inserts the card into a little machine, adds a few drop of the sample taken from the patient via a tube in the cardholder, and out come the results.'

A group of researchers from MiNaLaB at SINTEF has developed several techniques for interpreting the results when the biomarkers have been found. The results, for instance, can be read off in an optical instrument in which the RNA (ribonucleic acid) molecules in various markets emit specific fluorescent signals.

'SINTEF's lab-on-a-chip projects have shown that it is possible to perform rapid, straightforward diagnostic analyses with the aid of microchips, and we are now working on several different types of chip, including a protein analysis chip for acute inflammations,' Dr Furuberg said.

Keen to commercialise the results of their study, the researchers are working with a hospital acting as end user to validate system usability and clinical accuracy.

Researchers from Germany and Ireland contributed to this study.


Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

SINTEF
MICROACTIVE





  Top   Research Information Center